Unapproved New Drugs
Similar Posts
Infusion Pump Software Recall: Baxter Removes Sigma Spectrum Infusion System Platforms
This communication is part of the Communications Pilot to Enhance the Medical Device Recall ProgramInsufflation Unit Recall: Olympus Removes High Flow Insufflation Units
Olympus is removing certain High Flow Insufflation Unit models due to software issues that may lead to overpressure events.Obstetrics, Reproductive and Urologic Drugs Advisory Committee (formerly Bone, Reproductive and Urologic Drugs Advisory Committee) Roster
This page contains the Obstetrics, Reproductive and Urologic Drugs Advisory Committee (formerly Bone, Reproductive and Urologic Drugs Advisory Committee) Roster, which lists the current members and the current number of vacancies for the committee.Early Alert: Large Volume Pump Primary Administration Set Reverse Flow Issue from Fresenius Kabi
Some Ivenix LVP Primary Administration Sets were assembled with the drip chamber and Luer Lock components in reversed positions, potentially leading to clinical complicationsAbdallah Candies Issues a Voluntary Recall of Pecan Caramel Clusters Due to Undeclared, Mislabeled Allergens
Abdallah Candies is voluntarily recalling a specific lot of Pecan Caramel Clusters, due to a mislabeled allergen. Product contains Cashews that were not listed on the product label. Product was sold and distributed exclusively to Lunds & Byerlys, as a private label, sold in the state of Minnesota.Generic Drug Research Priorities & Projects
In accordance with the Generic Drug User Fee Amendments (GDUFA), FDA consults with industry and the public to create an annual list of regulatory science initiatives on generic drugs. These priorities are discussed and developed in public meetings and workshops, resulting in several awarded projects